Compare $CTKB vs $PACB | Chartloom

Compare

$CTKB vs $PACB

Cytek Biosciences Inc · Pacific Biosciences of California Inc

CTKB

Cytek Biosciences Inc

PACB

Pacific Biosciences of California Inc

Compare $CTKB vs $PACB

Comparing Cytek Biosciences Inc and Pacific Biosciences of California Inc

CTKBCytek Biosciences Inc

PACBPacific Biosciences of California Inc

CTKBCytek Biosciences Inc

Market cap

$701M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.18x

Rev growth (TTM)

5.4%

YTD performance

10.4%

52W performance

39.2%

FCF yield

-1.7%

PACBPacific Biosciences of California Inc

Market cap

$724M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.11x

Rev growth (TTM)

2.0%

YTD performance

26.6%

52W performance

54.3%

FCF yield

-18.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTKB

PACB

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

PACB

Pacific Biosciences of California Inc

Market Cap

CTKB$701M

PACB$724M

Enterprise Value

CTKB$637M

PACB$1.31B

Price

CTKB$5.43

PACB$2.33

P/E Ratio

CTKBN/A

PACBN/A

P/S Ratio

CTKB3.39x

PACB4.54x

EV/Sales

CTKB3.08x

PACB8.21x

EV/EBITDA

CTKB1,027.69x

PACB40.33x

P/B Ratio

CTKB2.37x

PACB333.69x

P/FCF Ratio

CTKBN/A

PACBN/A

EV/FCF

CTKB-52.35x

PACB-10.00x

PEG Ratio

CTKBN/A

PACBN/A

Forward P/E (NTM)

CTKBN/A

PACBN/A

Forward P/S (NTM)

CTKB3.18x

PACB4.11x

Revenue (TTM)

CTKB$207M

PACB$159M

Revenue Growth (YoY)

CTKB5.4%

PACB2.0%

Forward Rev Growth

CTKB6.1%

PACB15.4%

Gross Margin (TTM)

CTKB53.2%

PACB39.2%

Operating Margin (TTM)

CTKB0.0%

PACB0.0%

EBITDA Margin (TTM)

CTKB-17.9%

PACB-88.6%

Net Margin (TTM)

CTKB-39.0%

PACB-82.5%

FCF Margin (TTM)

CTKB-5.9%

PACB-82.0%

Net Income (TTM)

CTKB$-81M

PACB$-131M

FCF (TTM)

CTKB$-12M

PACB$-131M

EPS (TTM)

CTKB-$0.62

PACB-$0.42

ROE (TTM)

CTKB-2353.0%

PACB-48845.0%

ROA (TTM)

CTKB-1740.0%

PACB-1684.0%

ROIC (TTM)

CTKB-2293.0%

PACB-1914.0%

Cash

CTKB$74M

PACB$61M

Debt

CTKB$10M

PACB$644M

Net Cash/Debt

CTKB$64M

PACB$-583M

Current Ratio (TTM)

CTKB4.48x

PACB4.92x

Quick Ratio (TTM)

CTKB3.77x

PACB3.90x

Debt/Equity (TTM)

CTKB0.03x

PACB272.23x

Debt/Assets (TTM)

CTKB0.0%

PACB0.0%

Interest Coverage (TTM)

CTKBN/A

PACBN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

PACB0.00x

Beta

CTKB1.15

PACB2.25

52W Performance

CTKB39.2%

PACB54.3%

YTD Performance

CTKB10.4%

PACB26.6%

% from 52W High

CTKB-12.6%

PACB-32.2%

% from 52W Low

CTKB64.0%

PACB117.8%

Asset Turnover (TTM)

CTKB0.45x

PACB0.20x

FCF Yield (TTM)

CTKB-1.7%

PACB-18.1%

Earnings Yield (TTM)

CTKB-11.5%

PACB-18.2%

Dividend Yield (TTM)

CTKBN/A

PACBN/A

Rule of 40

CTKB-0.4

PACB-80.0

EV/GP/RG

CTKB0.61

PACB1.70

Ticker research

View CTKB research View PACB research

Metric	CTKB Cytek Biosciences Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$701M	$724M
Enterprise Value	$637M	$1.31B
Price	$5.43	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	4.54x
EV/Sales	3.08x	8.21x
EV/EBITDA	1,027.69x	40.33x
P/B Ratio	2.37x	333.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	4.11x
Revenue & Growth
Revenue (TTM)	$207M	$159M
Revenue Growth (YoY)	5.4%	2.0%
Forward Rev Growth	6.1%	15.4%
Profitability
Gross Margin (TTM)	53.2%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-88.6%
Net Margin (TTM)	-39.0%	-82.5%
FCF Margin (TTM)	-5.9%	-82.0%
Net Income (TTM)	$-81M	$-131M
FCF (TTM)	$-12M	$-131M
EPS (TTM)	-$0.62	-$0.42
ROE (TTM)	-2353.0%	-48845.0%
ROA (TTM)	-1740.0%	-1684.0%
ROIC (TTM)	-2293.0%	-1914.0%
Financial Health
Cash	$74M	$61M
Debt	$10M	$644M
Net Cash/Debt	$64M	$-583M
Current Ratio (TTM)	4.48x	4.92x
Quick Ratio (TTM)	3.77x	3.90x
Debt/Equity (TTM)	0.03x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	2.25
52W Performance	39.2%	54.3%
YTD Performance	10.4%	26.6%
% from 52W High	-12.6%	-32.2%
% from 52W Low	64.0%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.20x
FCF Yield (TTM)	-1.7%	-18.1%
Earnings Yield (TTM)	-11.5%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-80.0
EV/GP/RG	0.61	1.70
Ticker research	View CTKB research	View PACB research

Valuation

P/S Ratio

CTKB

3.39x

PACB

4.54x

EV/FCF

CTKB

-52.35x

PACB

-10.00x

Growth & revenue

Revenue Growth TTM

CTKB

5.4%

PACB

2.0%

Forward Revenue Growth

PACB

15.4%

CTKB

6.1%

Profitability & performance

Gross Margin

CTKB

53.2%

PACB

39.2%

ROE

CTKB

-2353.0%

PACB

-48845.0%

FCF Yield %

CTKB

-1.7%

PACB

-18.1%

52-Week Performance

PACB

54.3%

CTKB

39.2%

Detailed metrics comparison

CTKB

Cytek Biosciences Inc

PACB

Pacific Biosciences of California Inc

Market Cap

CTKB$701M

PACB$724M

Enterprise Value

CTKB$637M

PACB$1.31B

Price

CTKB$5.43

PACB$2.33

P/E Ratio

CTKBN/A

PACBN/A

P/S Ratio

CTKB3.39x

PACB4.54x

EV/Sales

CTKB3.08x

PACB8.21x

EV/EBITDA

CTKB1,027.69x

PACB40.33x

P/B Ratio

CTKB2.37x

PACB333.69x

P/FCF Ratio

CTKBN/A

PACBN/A

EV/FCF

CTKB-52.35x

PACB-10.00x

PEG Ratio

CTKBN/A

PACBN/A

Forward P/E (NTM)

CTKBN/A

PACBN/A

Forward P/S (NTM)

CTKB3.18x

PACB4.11x

Revenue (TTM)

CTKB$207M

PACB$159M

Revenue Growth (YoY)

CTKB5.4%

PACB2.0%

Forward Rev Growth

CTKB6.1%

PACB15.4%

Gross Margin (TTM)

CTKB53.2%

PACB39.2%

Operating Margin (TTM)

CTKB0.0%

PACB0.0%

EBITDA Margin (TTM)

CTKB-17.9%

PACB-88.6%

Net Margin (TTM)

CTKB-39.0%

PACB-82.5%

FCF Margin (TTM)

CTKB-5.9%

PACB-82.0%

Net Income (TTM)

CTKB$-81M

PACB$-131M

FCF (TTM)

CTKB$-12M

PACB$-131M

EPS (TTM)

CTKB-$0.62

PACB-$0.42

ROE (TTM)

CTKB-2353.0%

PACB-48845.0%

ROA (TTM)

CTKB-1740.0%

PACB-1684.0%

ROIC (TTM)

CTKB-2293.0%

PACB-1914.0%

Cash

CTKB$74M

PACB$61M

Debt

CTKB$10M

PACB$644M

Net Cash/Debt

CTKB$64M

PACB$-583M

Current Ratio (TTM)

CTKB4.48x

PACB4.92x

Quick Ratio (TTM)

CTKB3.77x

PACB3.90x

Debt/Equity (TTM)

CTKB0.03x

PACB272.23x

Debt/Assets (TTM)

CTKB0.0%

PACB0.0%

Interest Coverage (TTM)

CTKBN/A

PACBN/A

Net Debt/EBITDA (TTM)

CTKB0.00x

PACB0.00x

Beta

CTKB1.15

PACB2.25

52W Performance

CTKB39.2%

PACB54.3%

YTD Performance

CTKB10.4%

PACB26.6%

% from 52W High

CTKB-12.6%

PACB-32.2%

% from 52W Low

CTKB64.0%

PACB117.8%

Asset Turnover (TTM)

CTKB0.45x

PACB0.20x

FCF Yield (TTM)

CTKB-1.7%

PACB-18.1%

Earnings Yield (TTM)

CTKB-11.5%

PACB-18.2%

Dividend Yield (TTM)

CTKBN/A

PACBN/A

Rule of 40

CTKB-0.4

PACB-80.0

EV/GP/RG

CTKB0.61

PACB1.70

Ticker research

View CTKB research View PACB research

Metric	CTKB Cytek Biosciences Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$701M	$724M
Enterprise Value	$637M	$1.31B
Price	$5.43	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	3.39x	4.54x
EV/Sales	3.08x	8.21x
EV/EBITDA	1,027.69x	40.33x
P/B Ratio	2.37x	333.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.35x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.18x	4.11x
Revenue & Growth
Revenue (TTM)	$207M	$159M
Revenue Growth (YoY)	5.4%	2.0%
Forward Rev Growth	6.1%	15.4%
Profitability
Gross Margin (TTM)	53.2%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-17.9%	-88.6%
Net Margin (TTM)	-39.0%	-82.5%
FCF Margin (TTM)	-5.9%	-82.0%
Net Income (TTM)	$-81M	$-131M
FCF (TTM)	$-12M	$-131M
EPS (TTM)	-$0.62	-$0.42
ROE (TTM)	-2353.0%	-48845.0%
ROA (TTM)	-1740.0%	-1684.0%
ROIC (TTM)	-2293.0%	-1914.0%
Financial Health
Cash	$74M	$61M
Debt	$10M	$644M
Net Cash/Debt	$64M	$-583M
Current Ratio (TTM)	4.48x	4.92x
Quick Ratio (TTM)	3.77x	3.90x
Debt/Equity (TTM)	0.03x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.15	2.25
52W Performance	39.2%	54.3%
YTD Performance	10.4%	26.6%
% from 52W High	-12.6%	-32.2%
% from 52W Low	64.0%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.20x
FCF Yield (TTM)	-1.7%	-18.1%
Earnings Yield (TTM)	-11.5%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.4	-80.0
EV/GP/RG	0.61	1.70
Ticker research	View CTKB research	View PACB research